The FDA has denied Stealth BioTherapeutics’ request to reconsider its complete response letter, leaving the fate of the biotech and its investigational treatment for an ultrarare genetic disease ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 9, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
Geared Power Biotech Accepted Into The FDA's Safer Technologies Program For Its Bioguard UVCTM Device. EINPresswire/ -- Geared Power BioTech, a health technology startup, today announced that its ...
(RTTNews) - PDS Biotech (PDSB), a late-stage immunotherapy company focused on cancer treatments, announced Thursday that the U.S. Food and Drug Administration or FDA has cleared its Investigational ...
Levan, a β-(2,6)-linked fructose polymer, has emerged as a biopolymer of considerable interest for a range of biotechnological applications. Its synthesis is chiefly mediated by the enzyme ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
New Taipei City, Taiwan, March 27, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development ...
Hosted on MSN
EU unveils new biotech plan to boost its global competitiveness and close gap with China, US
The new Biotech Act, presented by the European Commission, aims to set up a framework that helps biotechnology reach the market faster, improving the bloc’s competitiveness over China, and the United ...
Among product types, D-galactose is expected to dominate the market with a 72.0% share in 2025. Its widespread use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results